Add BrightSurf on Google Email

Landing therapeutic genes safely in the human genome

A team of researchers at Harvard's Wyss Institute and ETH Zurich have developed a computational approach to identify genomic safe harbors (GSHs) with high potential for safe insertion of therapeutic genes. The study validated two GSH sites in adoptive T cell therapies and in vivo gene therapies for skin diseases.

SourceWyss Institute for Biologically Inspired Engineering at Harvard·JournalCell Reports Methods·TypeExperimental study·DateJan 24, 2022

Aging erodes genetic control, but that's flexible

Biologists at Brown University found that gene silencing via chromatin in fruit flies declines with age, but administering life span extending measures such as lower calorie diets or increased expression of the protein Sir2 restores the loss of gene silencing due to age. The study suggests a possible line of research to develop more pr...

Live broadcasts

Researchers have developed a genetically modified mouse model using the ferritin reporter gene, enabling live cell imaging via magnetic resonance imaging (MRI) without additional substances. This breakthrough overcomes limitations in detecting signal changes in tissues, such as fetal development and the central nervous system.

SourceWeizmann Institute of Science·JournalNature Medicine·DateJul 26, 2007